UNSPSC 41115830: Glucose analyzers

UNSPSC 41115830 Glucose analyzers is a Commodity code, but the recent opportunities posted under it reflect a much broader scope of medical diagnostic and emergency response equipment than the code name suggests. State and local governments are buying automated external defibrillators (AEDs) and accessories, transport ventilators, intraosseous infusion equipment, blood pressure monitoring systems, and metabolic measurement systems under this code. The issuing bodies span county governments (Williamson County, Marion County, Clay County, and Collier County in Florida; Cobb County in Georgia), school districts (Cobb County School District in Georgia; Klein Independent School District in Texas), and state universities (GSW State University in Georgia, Lamar University in Texas). Sole-source and re-solicitation procurements dominate the activity, often driven by equipment standardization needs or clinical compatibility requirements with existing EMS and hospital infrastructure.

Recent opportunities cluster in Florida and Georgia. Williamson County issued an IFB for EZ-IO intraosseous infusion equipment (needles, stabilizers, and drills) for Emergency Medical Services with a deadline of July 7, 2026. Marion County, Florida, re-solicited blood pressure cuffs and hoses compatible with the LIFEPAK 15S defibrillator for fire rescue operations, with proposals due May 6, 2026. Clay County, Florida, pursued Hamilton-T1 transport ventilators through sole-source procurement to replace discontinued units in the fire rescue fleet. Cobb County School District requested quotes for AED equipment, batteries, and accessories with an estimated budget of approximately $50,000 and a deadline of July 6, 2026. GSW State University in Georgia issued an eRFQ for a Metabolic Measurement System–Compact Analyzer Module with a May 4, 2026 response date. A Sourcewell cooperative purchasing RFP (RFP #061626) for law enforcement equipment, responding to June 16, 2026, serves multiple Washington state counties and jurisdictions across the United States and Canada, though the scope of that opportunity does not clearly align with glucose analyzers or medical diagnostics.